Target,Reference Ab,Method,HCDRs Designed,HCDR1,HCDR2,HCDR3,KD (nM),heavy,light,fitness
C5,Eculizumab,Positive Control,,GYIFSNYW,ILPGSGST,ARYFFGSSPNWYFDV,0.26890417075,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYFFGSSPNWYFDVWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,0.26890417075
C5,Eculizumab,SAbDab,HCDR3,GYIFSNYW,ILPGSGST,ARDRFDVASGSSFDF,325.00000000000006,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDRFDVASGSSFDFWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,325.00000000000006
C5,Eculizumab,SAbDab,HCDR3,GYIFSNYW,ILPGSGST,ARDRSYGDSSWALDA,3979.999999999998,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARDRSYGDSSWALDAWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,3979.999999999998
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYYGDTPFIYFDY,96.3000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYYGDTPFIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,96.3000000000001
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLRWGDTPIIYFDY,749.0000000000003,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLRWGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,749.0000000000003
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYRWGDTPIIYFDY,502.0000000000004,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRWGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,502.0000000000004
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLRYGDTPTIYFDY,468.99999999999966,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLRYGDTPTIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,468.99999999999966
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYYGDTPTIYFDY,111.00000000000004,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYYGDTPTIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,111.00000000000004
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYRYGDTPTIYFDY,689.0000000000005,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPTIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,689.0000000000005
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYRYGDTPYIYFDY,582.9999999999994,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,582.9999999999994
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYRYGDTPFIYFDY,385.00000000000034,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPFIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,385.00000000000034
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLYYGDTPYIYFDY,492.0000000000003,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLYYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,492.0000000000003
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYRWGDTPYIYFDY,850.0000000000002,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRWGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,850.0000000000002
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLRYGDTPFIYFDY,936.9999999999998,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLRYGDTPFIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,936.9999999999998
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYWGDTPIIYFDY,161.99999999999994,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYWGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,161.99999999999994
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYWGDTPYIYFDY,203.9999999999998,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYWGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,203.9999999999998
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARFRYGDTPIIYFDY,280.0000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARFRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,280.0000000000001
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLYYGDTPIIYFDY,323.99999999999994,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLYYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,323.99999999999994
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYEYGDTPIIYFDY,275.0000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYEYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,275.0000000000001
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYYGDTPIIYFDY,125.99999999999989,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,125.99999999999989
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYYYGDTPYIYFDY,127.00000000000011,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,127.00000000000011
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARYEYGDTPYIYFDY,915.0000000000005,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYEYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,915.0000000000005
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARLRYGDTPYIYFDY,2510.000000000002,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLRYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,2510.000000000002
C5,Eculizumab,Inverse Folding,HCDR3,GYIFSNYW,ILPGSGST,ARHYYGDTPDIYFDY,1700.000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYIFSNYWIQWVRQAPGQGLEWMGEILPGSGSTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARHYYGDTPDIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,1700.000000000001
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IKPGSGYT,ARYRYGDTPIIYFDY,506.9999999999996,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIKPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,506.9999999999996
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGET,ARYRYGDTPIIYFDY,251.00000000000017,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGETEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,251.00000000000017
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IKPGSGYT,ARHEYGDTPIIYFDY,292.9999999999998,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIKPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARHEYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,292.9999999999998
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGET,ARYRYGDTPYIYFDY,399.00000000000017,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGETEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,399.00000000000017
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGYT,ARYYYGDTPYIYFDY,266.99999999999983,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYYYGDTPYIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,266.99999999999983
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IQPGSGYT,ARYRYGDTPIIYFDY,622.0000000000007,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIQPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,622.0000000000007
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGYT,ARLRYGDTPIIYFDY,3599.9999999999964,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARLRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,3599.9999999999964
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGYT,ARYRYGDTPFIYFDY,1190.000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPFIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,1190.000000000001
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGYT,ARYRYGDTPIIYFDY,2300.000000000001,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPIIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,2300.000000000001
C5,Eculizumab,Inverse Folding,HCDR123,GYTFTSYW,IHPGSGYT,ARYRYGDTPDIYFDY,596.9999999999999,QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYWIQWVRQAPGQGLEWMGEIHPGSGYTEYTENFKDRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARYRYGDTPDIYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCGASENIYGALNWYQQKPGKAPKLLIYGATNLADGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQNVLNTPLTFGQGTKVEIK,596.9999999999999
